DHPS

deoxyhypusine synthase

Basic information

Region (hg38): 19:12675717-12681880

Links

ENSG00000095059NCBI:1725OMIM:600944HGNC:2869Uniprot:P49366AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neurodevelopmental disorder with seizures and speech and walking impairment (Limited), mode of inheritance: AR
  • neurodevelopmental disorder with seizures and speech and walking impairment (Moderate), mode of inheritance: AR
  • neurodevelopmental disorder with seizures and speech and walking impairment (Strong), mode of inheritance: AR
  • neurodevelopmental disorder with seizures and speech and walking impairment (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neurodevelopmental disorder with seizures and speech and walking impairmentARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic30661771

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DHPS gene.

  • not_specified (43 variants)
  • not_provided (19 variants)
  • DHPS-related_disorder (10 variants)
  • Neurodevelopmental_disorder_with_seizures_and_speech_and_walking_impairment (5 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DHPS gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001930.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
8
clinvar
3
clinvar
11
missense
1
clinvar
44
clinvar
1
clinvar
46
nonsense
1
clinvar
1
start loss
1
1
frameshift
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
Total 1 4 46 9 3

Highest pathogenic variant AF is 0.00033649377

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DHPSprotein_codingprotein_codingENST00000210060 96186
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0001630.97212559801501257480.000597
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3932492321.070.00001392423
Missense in Polyphen85101.980.83351082
Synonymous-0.7831121021.100.00000684738
Loss of Function1.96918.00.5008.60e-7197

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006810.000680
Ashkenazi Jewish0.001400.00139
East Asian0.0002720.000272
Finnish0.0005090.000508
European (Non-Finnish)0.0006800.000677
Middle Eastern0.0002720.000272
South Asian0.0006550.000653
Other0.0006540.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the NAD-dependent oxidative cleavage of spermidine and the subsequent transfer of the butylamine moiety of spermidine to the epsilon-amino group of a critical lysine residue of the eIF-5A precursor protein to form the intermediate deoxyhypusine residue. This is the first step of the post- translational modification of that lysine into an unusual amino acid residue named hypusine. Hypusination is unique to mature eIF- 5A factor and is essential for its function.;
Pathway
Post-translational protein modification;Metabolism of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;hypusine biosynthesis;Hypusine synthesis from eIF5A-lysine (Consensus)

Recessive Scores

pRec
0.164

Intolerance Scores

loftool
0.918
rvis_EVS
-0.53
rvis_percentile_EVS
20.7

Haploinsufficiency Scores

pHI
0.267
hipred
N
hipred_score
0.429
ghis
0.590

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
H
gene_indispensability_pred
E
gene_indispensability_score
0.923

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Dhps
Phenotype
immune system phenotype; renal/urinary system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
dhps
Affected structure
primary islet
Phenotype tag
abnormal
Phenotype quality
has fewer parts of type

Gene ontology

Biological process
translation;spermidine metabolic process;positive regulation of cell population proliferation;peptidyl-lysine modification to peptidyl-hypusine
Cellular component
cytoplasm;cytosol
Molecular function
protein binding;deoxyhypusine synthase activity;identical protein binding